Quest Diagnostics Incorporated

Quest Diagnostics is a U.S.-based clinical laboratory company that provides diagnostic testing, pathology, and related information services through a nationwide network of laboratories and patient service centers. It also operates diagnostic solutions businesses that serve insurers and healthcare organizations with risk assessment and healthcare IT services.

19,3 %

33,2 %

9,0 %

+11,8 %

1.04

0.96

— Quest Diagnostics Incorporated
%
Diagnostic Information Services97% Core clinical lab testing, pathology, and diagnostic insights delivered to healthcare providers and patients.
Diagnostic Solutions - Risk Assessment1% Testing and analytics services used by insurers to support underwriting and risk evaluation.
Diagnostic Solutions - Healthcare IT2% Connectivity and information technology tools for providers and payers, including workflow and data services.

Quest sells primarily into the healthcare ecosystem, with physicians, hospitals, and patients/consumers as its main...

  • Physicians and physician groupsprimary

    Order routine and specialty diagnostic tests for patient diagnosis, treatment, and follow-up.

  • Hospitals and health systemsprimary

    Buy outsourced laboratory and pathology services to extend capacity and access specialized testing.

  • Patients and consumersprimary

    Use Quest's network for direct access, convenience testing, and specimen collection services.

  • Health plans and insurerssecondary

    Use risk assessment and diagnostic services to support utilization, underwriting, and care management.

  • Employers, pharma, and government agenciessecondary

    Buy testing, screening, and data-enabled services for workforce, research, and public health needs.

Quest's business is centered in the United States, where it operates its headquarters, laboratories, patient service...

  • Headquartered in Secaucus, New Jersey
  • Nationwide U.S. laboratory and patient service center network
  • Primary revenue exposure is the United States healthcare market
  • Selected operations outside the United States are limited
  • Puerto Rico appears in community and service disclosures

Quest's strategy centers on expanding testing breadth, improving access, and using its scale and data assets to support...

01
Broaden diagnostic menu and specialty capabilitiesmedium-term

A wider test menu increases relevance with physicians, hospitals, and consumers and supports cross-selling.

02
Increase access and conveniencemedium-term

Convenient specimen collection and broad network coverage help capture more test volume as care shifts outside hospitals.

03
Use data and analytics in care managementlong-term

Diagnostic data can improve population health workflows and support value-based care relationships.

04
Drive productivity and service qualityshort-term

Laboratory testing is operationally intensive, so efficiency gains can improve competitiveness and service consistency.

Quest faces regulatory, reimbursement, and operational risks typical of large clinical laboratory businesses, including...

high

Healthcare market and reimbursement changes

Quest depends on payer mix, fee schedules, and test utilization, so pricing and volume can be affected by policy and payer actions.

Scope
Clinical laboratory testing and diagnostic services
Materiality
high
high

Regulatory and compliance risk

Clinical labs operate under complex federal and state rules, including CLIA, billing, and medical practice requirements.

Scope
Testing, specimen collection, and partner channels
Materiality
high
high

Data privacy and cybersecurity

The company handles sensitive patient and health information and uses large data assets in its services.

Scope
Healthcare IT, diagnostics data, and consumer services
Materiality
high
medium

Acquisition integration and execution

Quest uses acquisitions to expand capabilities, but integration can create cost, operational, and service risks.

Scope
Clinical testing assets and specialty businesses
Materiality
medium
medium

Shifts in healthcare delivery and consumer behavior

More care in retail, telemedicine, and home settings changes how specimens are collected and how customers access testing.

Scope
Patient access network and mobile phlebotomy
Materiality
medium
Revenue per requisition and mix effects
Affects top-line growth interpretation and organic performance analysis
Intangible asset amortization
Impacts operating income and net income
Contingent consideration
Can add volatility to operating results
Impairment and exit-related charges
Affects operating expense and comparability
Restructuring and integration costs
Distorts underlying operating margin trends

: 11/08/2026